Growth Factor Therapy in Wound Care: Platelet-Rich Plasma

Growth Factor Therapy in Wound Care: PRP Science and Practice

Growth factor therapy represents a biological approach to chronic wound management that uses the patient's own healing signals to accelerate tissue repair. Platelet-rich plasma (PRP) is the most accessible and widely studied growth factor therapy in wound care, offering clinicians a treatment option that can be prepared chairside from a simple blood draw.

The concept is straightforward: platelets contain concentrated growth factors (PDGF, TGF-beta, VEGF, EGF, and others) that initiate and regulate wound healing. By concentrating these platelets and applying them directly to the wound bed, the clinician delivers a supraphysiologic dose of healing signals exactly where they are needed.

How PRP Works: The Science

When platelets activate at a wound site, they release growth factors stored in their alpha granules. In a normal wound, this process happens naturally but at physiologic concentrations. PRP concentrates platelets to 3-8 times baseline levels, delivering a proportional increase in growth factor concentration.

Key Growth Factors in PRP

PDGF (Platelet-Derived Growth Factor): Recruits and activates macrophages and fibroblasts. Stimulates collagen synthesis and angiogenesis.
TGF-beta (Transforming Growth Factor Beta): Promotes extracellular matrix production. Regulates cell proliferation and differentiation.
VEGF (Vascular Endothelial Growth Factor): Drives new blood vessel formation (angiogenesis). Critical for granulation tissue development.
EGF (Epidermal Growth Factor): Stimulates epithelial cell migration and proliferation. Promotes wound closure.
FGF (Fibroblast Growth Factor): Promotes fibroblast proliferation and collagen synthesis. Supports tissue remodeling.

These growth factors work synergistically. The value of PRP over a single recombinant growth factor (such as becaplermin/Regranex) is this multi-factor delivery that mirrors the biological complexity of natural wound healing.

For broader context on growth factor therapies and biologics in wound care, see Growth Factors and Biologics in Wound Care.

PRP Preparation and Application

Blood Collection and Processing

PRP preparation requires a venous blood draw (typically 30-60 mL depending on the system), an FDA-cleared PRP preparation kit, and a centrifuge. The process takes approximately 15-20 minutes.

Steps:

Draw venous blood into tubes containing anticoagulant (typically sodium citrate)
Centrifuge at the speed and duration specified by the preparation system (single-spin or double-spin protocols vary by manufacturer)
Separate the platelet-rich layer from the red blood cell and platelet-poor plasma layers
Activate the PRP with calcium chloride or thrombin immediately before application (some protocols use non-activated PRP)

Application Technique

Direct application: Activated PRP is applied as a liquid or gel directly to the wound bed after thorough wound preparation (debridement of necrotic tissue, cleansing). Cover with a non-adherent dressing.

PRP gel: Mixing activated PRP with thrombin creates a gel consistency that stays in place on the wound surface. This is preferable for wounds with irregular topography or tunneling.

PRP-infused matrices: PRP can be combined with a collagen matrix or other scaffold material for wounds requiring both growth factor delivery and structural support.

Wound Bed Preparation

PRP application requires a clean, well-prepared wound bed. Debride necrotic tissue and biofilm before application. PRP applied to a necrotic or biofilm-covered wound bed will not reach viable tissue and will not produce the desired response.

Patient Selection: Who Benefits from PRP

PRP is not a first-line therapy for every wound. It occupies a specific position in the treatment escalation pathway for wounds that have failed standard care.

Appropriate Candidates

Chronic wounds that have failed to show healing progress after 4+ weeks of standard care
Diabetic foot ulcers with adequate perfusion (ABI > 0.7) that are not responding to offloading and moist wound healing alone
Venous leg ulcers with adequate compression therapy that remain stalled
Surgical wounds with delayed healing
Patients who cannot receive or have failed skin substitute/CTP therapy

Contraindications

Active wound infection (treat infection first, then consider PRP)
Platelet disorders or thrombocytopenia (<100,000/uL)
Patients on antiplatelet therapy (relative contraindication; some clinicians proceed with adjusted expectations)
Malignancy at or near the wound site
Hemodynamic instability

Evidence Base

The evidence for PRP in wound care is growing but remains mixed depending on wound type. A systematic review and meta-analysis published in the International Wound Journal found that PRP significantly improved healing rates in diabetic foot ulcers compared to standard care. Evidence for venous leg ulcers is less robust, with some trials showing benefit and others showing no significant difference.

The key limitation of the evidence base is heterogeneity. PRP preparation methods, platelet concentrations, activation protocols, and application frequencies vary widely across studies, making direct comparisons difficult.

For a broader view of evidence-based wound care practices, including how to evaluate emerging therapies, see Evidence-Based Practice in Wound Care.

Billing Considerations for PRP in Wound Care

PRP billing in wound care requires careful attention to payer coverage policies, as coverage is inconsistent.

Medicare Coverage

Medicare coverage for PRP in wound care is limited. Most MACs do not have a specific LCD covering PRP for chronic wounds. Some MACs have issued non-coverage determinations. Before incorporating PRP into your practice, review your MAC's specific policies.

Important: The absence of an LCD does not automatically mean coverage. It means there is no formal local policy, and claims may be adjudicated on a case-by-case basis.

CPT Coding

0232T (Category III code): Injection(s), platelet-rich plasma, any site, including image guidance, harvesting, and preparation when performed
Note that Category III codes are tracking codes and may not be recognized by all payers

Documentation Requirements

Regardless of payer, document:

Medical necessity: why standard care has failed (include timeline, measurements showing lack of progress, treatments attempted)
Wound bed preparation performed prior to PRP application
PRP preparation details: volume drawn, system used, platelet concentration achieved if measured
Application technique and volume applied
Follow-up plan and expected treatment frequency

Key Takeaways

PRP delivers a concentrated dose of autologous growth factors (PDGF, TGF-beta, VEGF, EGF) to the wound bed, mimicking and amplifying the natural healing cascade
Patient selection is critical: PRP is appropriate for chronic wounds that have failed 4+ weeks of standard care, with adequate perfusion and no active infection
Wound bed preparation (debridement, biofilm removal) before PRP application is essential for clinical efficacy
Medicare coverage for PRP in wound care remains limited and inconsistent; verify MAC-specific policies before incorporating into practice
Document medical necessity, failed standard care timeline, preparation details, and application technique for every PRP treatment